支气管动脉栓塞术治疗支气管扩张引起少量咯血的临床价值-现代医学

支气管动脉栓塞术治疗支气管扩张引起少量咯血的临床价值

单位：空军军医大学唐都医院介入放射科, 陕西西安 710038

分类号：R562.22;R563.6

出版年·卷·期（页码）：2018·37·第九期（1025-1029）

摘要：

目的：探讨支气管动脉栓塞术治疗支气管扩张引起少量咯血的临床价值。方法：回顾性分析60例支气管扩张引起少量咯血的患者。所有患者胸主动脉CT成像均提示支气管动脉畸形，其中30例患者行支气管动脉栓塞术+药物治疗（介入组），另30例患者仅接受药物治疗（对照组）。对比两组患者治疗后咯血停止时间、2年内咯血复发率以及出现大咯血的比率。结果：介入组30例患者治疗后咯血停止时间为（2.3±0.3） d，2年内咯血复发率为23.3%（7/30），出现大咯血比率为6.7%（2/30）%；对照组30例患者治疗后咯血停止时间为（4.5±0.4） d，2年内咯血复发率为56.7%（17/30），出现大咯血比率为30.0%（9/30）。两组比较，差异有统计学意义（P<0.05）。结论：支气管动脉栓塞术联合药物治疗相比于仅使用药物治疗对支气管扩张引起的少量咯血患者的止血效果更快速有效，同时可以更有效地预防日后咯血复发以及大咯血的发生。

Objective: To investigate the clinical effects of bronchial artery embolization (BAE) in the treatment of minor hemoptysis induced by bronchiectasis. Methods: Retrospective analysis of data from 60 patients with minor hemoptysis induced by bronchiectasis was done. The bronchial artery abnormalities were suggested by thoracic aorta CT angiography (CTA), 30 patients were treated by BAE combined with drugs (intervention group), and the other 30 patients were treated with drugs only (control group). Then after treatment, the stop time of hemoptysis, the recurrence rate of hemoptysis, and the occurrence rate of massive hemoptysis in 2 years were compared between the two groups. Results: Among all 60 cases after treatment, the stop time of hemoptysis, the recurrence rate of hemoptysis, and the occurrence rate of massive hemoptysis in 2 years were (2.3±0.3) days, 23.3% (7/30), 6.7% (2/30) in the intervention group, while those in the control group were (4.5±0.4) days, 56.7%(17/30), 30.0%(9/30). There were statistically significant differences between the two groups for all these factors (P<0.05). Conclusion: The BAE combined with drug treatment is faster and more effective than drug treatment only for minor hemoptysis induced by bronchiectasis, and it can also effectively prevent the recurrence of hemoptysis and the occurrence of massive hemoptysis.

参考文献：

[1] KHALIL A,FEDIDA B,PARROT A,et al.Severe hemoptysis:from diagnosis to embolization[J].Diagn Interv Imaging,2015,96(7-8):775-788.
[2] HAHN S,KIM Y J,KWON W,et al.Comparison of the effectiveness of embolic agents for bronchial artery embolization:gelfoam versus polyvinyl alcohol[J].Korean J Radiol,2010,11(5):542-546.
[3] 王国安,吴宏成,吴仕波,等.支气管动脉栓塞介入治疗支气管扩张大咯血205例疗效分析[J].中国呼吸与危重监护杂志,2013,12(1):85-88.
[4] THÉONE S,ADLER D,SCHNEIDER P A,et al.Management of massive hemoptysis[J].Rev Med Suisse,2015,11(495):2157-2162.
[5] 万学红,卢雪峰.诊断学[M].8版.北京:人民卫生出版社,2013:17-19.
[6] DALIRI A,PROBST N H,JOBST B,et al.Bronchial artery embolization in patients with hemoptysis including follow-up[J].Acta Radiol,2011,52(2):143-147.
[7] FRUCHTER O,SCHNEER S,RUSANOV V,et al.Bronchial artery embolization for massive hemoptysis:long-term follow-up[J].Asian Cardiovasc Thorac Ann,2015,23(1):55-60.
[8] CORNALBA G P,VELLA A,BARBOSA F,et al.Bronchial and nonbronchial systemic artery embolization in managing haemoptysis:31 years of experience[J].Radiol Med,2013,118(7):1171-1183.
[9] 谢灿果.选择性支气管动脉栓塞术在治疗支气管扩张引起的咯血时的临床疗效体会[J].实用心脑肺血管病杂志,2016,24(B04):80-82.
[10] 罗金华,程琪,马威.全程护理对肺结核病咯血病人的疗效研究[J].现代医学,2014,42(4):449-452.
[11] 王晓东.介入治疗大咯血的临床疗效及复发率观察[J].中国现代药物应用,2016,10(11):203-204.
[12] LIU H,ZHANG D,ZHANG F,et al.Immediate and long-term outcomes of endovascular treatment for massive hemoptysis[J].Int Angiol,2016,35(5):469-476.
[13] 单明,畅智慧,王传卓,等.支气管动脉栓塞术后再发咯血的危险因素分析[J].中华介入放射学电子杂志,2014,2(2):40-43.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录